• Azithromycin: From Ribosome to Translation Strategy

  2026-09-13

  Azithromycin is more than a familiar macrolide antibiotic: it is a mechanistically traceable tool for connecting ribosomal inhibition, resistance biology, microbial ecology, and translational model design. This article shows how to use Azithromycin rigorously in bacterial infection research while defining the evidence boundaries for microbiome, metabolome, and trypanosomosis animal model applications.

• Gap19: Precision Cx43 Blockade for Translation

  2026-09-12

  Gap19 offers a mechanistically focused way to study Cx43 hemichannel signaling without intentionally disrupting gap junction communication. This thought-leadership analysis connects astrocyte ATP release, ischemic neuroprotection, macrophage inflammation, and translational study design while separating established evidence from forward-looking hypotheses.

• Solanesol Workflow and QC Guide

  2026-09-11

  Solanesol (SKU B8776) provides a defined hydrophobic polyisoprenoid alcohol for biochemical, membrane-related, cell-based, and enzyme workflow development. This guide explains DMSO preparation, fresh-solution handling, solvent controls, and QC boundaries; the material is insoluble in water and ethanol and is intended only for scientific research, not diagnostic or medical use.

• SAG for Mechanism-First Hedgehog Assays

  2026-09-11

  SAG is a Smoothened receptor agonist that enables direct Hedgehog pathway manipulation in neural, mitochondrial, and developmental models. This guide translates astrocyte–neuron evidence into practical assay design, controls, dosing logic, and interpretation.

• Nullscript: Histone Deacetylase Inhibitor Guide

  2026-09-10

  Nullscript is a distinctive histone deacetylase inhibitor for separating HDAC target engagement from transcriptional facilitation. Its inactive p6SBE-luc profile, analog relationship to scriptaid, and reported cardiac protection make it useful for mechanistic assay design across chromatin, injury, and stress-response models.

• Quaternization Reprograms mRNA Lung Tropism

  2026-09-10

  The reference study shows that N-quaternization of the lipid-like compound tB-UC18 converts mRNA-loaded nanoassemblies from spleen-preferential to highly lung-selective delivery after intravenous administration in mice. Its findings identify head-group chemistry as a relatively simple design variable for non-liver mRNA delivery, while also highlighting the need to distinguish organ distribution, cellular uptake, and productive translation.

• Carbenoxolone disodium: Practical Lab Guide

  2026-09-09

  Carbenoxolone disodium is a research perturbation tool for examining 11β-hydroxysteroid dehydrogenase activity, glucocorticoid access, corticosterone metabolism, and gap junction communication. It is best used in controlled enzyme, cell, or tissue workflows with matched-vehicle, viability, and orthogonal pathway controls rather than as a selective target-validation reagent or established in vivo efficacy compound.

• Bleomycin Sulfate: From DNA Damage to Fibrosis

  2026-09-09

  Bleomycin Sulfate is more than a cytotoxic reagent: it is a controllable perturbation for connecting DNA damage with macrophage-driven pulmonary fibrosis. This article shows how to pair its molecular mechanism with multi-layered assay design and emerging STING-focused therapeutic research.

• Plk1 Control of p31comet in Checkpoint Exit

  2026-09-08

  The 2019 PNAS study identifies Polo-like kinase 1 (Plk1) as a negative regulator of p31comet-mediated mitotic checkpoint complex disassembly. Its evidence supports a phosphorylation-based brake that prevents premature checkpoint turnover while chromosomes remain unattached, offering a useful framework for interpreting mitotic kinase perturbation experiments.

• HyperPFU™ high-fidelity DNA polymerase guide

  2026-09-08

  HyperPFU™ high-fidelity DNA polymerase is designed for accurate amplification of long, GC-rich, and otherwise difficult DNA templates where standard Taq-based workflows may be inadequate. It produces blunt-ended amplicons, so it should not be selected for protocols that require 3′-A overhangs or preformed sticky ends.

• Liraglutide and the Brain–Kidney AVP Axis

  2026-09-07

  Greenwood and colleagues connect liraglutide treatment with reduced circulating arginine vasopressin, sex- and time-dependent pituitary synaptic phosphorylation, and downstream aquaporin 2 regulation. By combining clinical endocrinology, rat pituitary omics, a functional AVP luciferase assay, and renal analysis, the study provides a multilevel framework for understanding how GLP-1 receptor agonists may influence fluid balance.

• Sinapine Disrupts the Gαq–PLCβ3 Axis in CVD

  2026-09-07

  A 2024 Phytomedicine study identifies sinapine as a selective disruptor of the Gαq–PLCβ3 interaction, acting through the PLCβ3 EF-hand region and Asn-260 rather than broadly inhibiting Gαq. Chemical proteomics, biochemical experiments, and aldosteronism and hypertension models connect this protein–protein interaction mechanism with improved cardiovascular phenotypes.

• 7-Ethyl-10-hydroxycamptothecin in Assay Design

  2026-09-05

  Explore how 7-Ethyl-10-hydroxycamptothecin (SN-38) can be used to build mechanistically resolved cancer assays rather than relying on viability alone. This guide connects topoisomerase I inhibition, FUBP1–FUSE disruption, cell-cycle analysis, and apoptosis readouts to practical advanced colon cancer research.

• Arachidonic Acid: Immune Signaling Workflows

  2026-09-04

  Use Arachidonic Acid to connect membrane lipid release with eicosanoid biosynthesis, inflammation models, and vaccine-response assays. This practical guide emphasizes controlled dosing, pathway-resolved readouts, and translation of new humoral-immunity findings into reproducible bench workflows.

• Dehydroepiandrosterone (DHEA): Research Guide

  2026-09-04

  Dehydroepiandrosterone (DHEA) is an endogenous steroid intermediate with reported neuroprotective, antiapoptotic, and ovarian research applications. Its effects are model-dependent, so concentration, exposure time, solvent, and endpoint selection must be controlled.

7973 records 1/532 page Next 12345 下5页 Last page